A/Prof Leslie Reti – Chair

Dr Leslie Reti is a Director on the Board of the Peter MacCallum Cancer Centre, he is the Chair of the Quality Committee and a member of the Finance Committee.

He is Clinical Director of Clinical Governance at the Royal Women’s Hospital.

Dr Reti was co-founder of the Centre Against Sexual Assault (CASA House) at the Women’s. He was an executive member of the Victorian Council on Safety and Quality in Health and has been Chair of the QA Committee at The Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG). He received the 2013 RANZCOG Distinguished Service Medal.

Dr Reti was also named the recipient of the 2013 Victorian Public Healthcare Lifetime Achievement Award.

Siegi Schmidmaier – Director

Ms Siegi Schmidmaier is an executive with Silver Chain Group, a national provider of home based health and aged care. Siegi leads the strategy portfolio that includes innovation, digital futures, communications, and partnerships.  She has held a number of executive leadership roles including the Executive Director of Strategy at the Peter MacCallum Cancer Centre, where she sponsored pathology and led the clinical and academic team in conceptualising the national Centre of Excellence in Cell Therapies.

Ms Schmidmaier has a strong interest in creating new projects and business units that introduce new technology, innovation and a commercial focus to the traditional clinical and medical technology setting.

Previously, Ms Schmidmaier held roles with the Department of Prime Minister and Cabinet, Victorian Minister for Health, Victorian Department of Health and Ageing, and an international consulting firm.

Ms Schmidmaier is a Graduate of the Australian Institute of Company Directors, has a Master of Science (Public Health), a Bachelor of Nursing, and Graduate Diploma of Project Management.

 

Mr Peter Turvey – Director

Mr. Turvey has had more than 30 years experience in the biotech/pharmaceutical industry having been former Executive Vice- President Licensing, Group General Counsel and Company Secretary of global biopharmaceutical company CSL Limited, retiring in 2011. Mr Turvey is currently a non-executive director of ASX listed Starpharma Holdings Ltd as well as the Chair of its Audit and Risk Committee, and non-executive director of the Victorian Government-owned entities Agriculture Victoria Services Pty. Ltd. and Phytogene Pty Ltd and the oncolytic virus research company Immvirx Pty. Ltd.

Mr Turvey played a key role in the transformation of CSL from a government-owned entity , through ASX-listing in 1994 to a global plasma biopharmaceutical company. He also had responsibility for the protection and licensing of CSL’s intellectual property and for risk management within CSL, which included management of the internal audit function as well as being Chairman of the Corporate Risk Management Committee.